| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.069 | 0.04 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.04 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.077 | 0.04 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.04 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.04 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.04 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.062 | 0.04 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.05 |